Evidence map›Paper›PMID 22760459›Full record

GuidelineSchmerz (Berlin, Germany)2012

[Fibromyalgia syndrome. General principles and coordination of clinical care and patient education].

W Eich, W Häuser, B Arnold, K Bernardy, W Brückle, U Eidmann, K Klimczyk, V Köllner, H Kühn-Becker, M Offenbächer and 4 more

Abstract readConsensus StatementEnglish AbstractPractice Guideline
PubMed Publisher
In one paragraph

Guideline in Schmerz (Berlin, Germany), 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 6 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 6 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 6 syntheses or guidelines pooled it.

  1. Pooled it
  2. Oral nonsteroidal anti-inflammatory drugs for fibromyalgia in adults.The Cochrane database of systematic reviews · 2017
    Pooled it
  3. Gabapentin for fibromyalgia pain in adults.The Cochrane database of systematic reviews · 2017
    Pooled it
  4. Cannabinoids for fibromyalgia.The Cochrane database of systematic reviews · 2016
    Pooled it
  5. Antipsychotics for fibromyalgia in adults.The Cochrane database of systematic reviews · 2016
    Pooled it
  6. Cognitive behavioural therapies for fibromyalgia.The Cochrane database of systematic reviews · 2013
    Pooled it
  7. Trial
  8. Article
  9. Article
  10. Pregabalin for pain in fibromyalgia in adults.The Cochrane database of systematic reviews · 2016
    Review
  11. Oxycodone for pain in fibromyalgia in adults.The Cochrane database of systematic reviews · 2016
    Review
  12. Review
  13. Article
  14. Review
  15. Review
  16. Non-specific, functional, and somatoform bodily complaints.Deutsches Arzteblatt international · 2012
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

W EichKlinik für Allgemeine Innere Medizin und Psychosomatik, Universitätsklinikum Heidelberg, Im Neuenheimer Feld 10, 69210, Heidelberg, Deutschland. wolfgang.eich@med.uni-heidelberg.de
W Häuser
B Arnold
K Bernardy
W Brückle
U Eidmann
K Klimczyk
V Köllner
H Kühn-Becker
M Offenbächer
M Settan
M von Wachter
F Petzke
Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe scheduled update to the German S3 guidelines on fibromyalgia syndrome (FMS) by the Association of the Scientific Medical Societies ("Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften", AWMF; registration number 041/004) was planned starting in March 2011. MATERIALS AND

methodsThe development of the guidelines was coordinated by the German Interdisciplinary Association for Pain Therapy ("Deutsche Interdisziplinären Vereinigung für Schmerztherapie", DIVS), 9 scientific medical societies and 2 patient self-help organizations. Eight working groups with a total of 50 members were evenly balanced in terms of gender, medical field, potential conflicts of interest and hierarchical position in the medical and scientific fields. Literature searches were performed using the Medline, PsycInfo, Scopus and Cochrane Library databases (until December 2010). The grading of the strength of the evidence followed the scheme of the Oxford Centre for Evidence-Based Medicine. The formulation and grading of recommendations was accomplished using a multi-step, formal consensus process. The guidelines were reviewed by the boards of the participating scientific medical societies. RESULTS AND

conclusionA diagnosis of FMS should be explicitly communicated with the afflicted individual. A step-wise treatment, depending on the severity of FMS and the responses to therapeutic measures, is recommended. Therapy should only be continued if the positive effects outweigh the side effects. The English full-text version of this article is available at SpringerLink (under "Supplemental").

Indexed as

Cooperative BehaviorInterdisciplinary CommunicationPatient Care TeamPatient Education as TopicAdultCombined Modality TherapyCommunicationEvidence-Based MedicineFibromyalgiaHumansIntractable PainPatient AdmissionPatient-Centered CareRehabilitation CentersSomatoform Disorders

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.